- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia Acute Promyelocytic Leukemia (APL) in Austria
Total 894 results
-
TakedaActive, not recruitingPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)United States, China, Spain, Australia, Canada, Argentina, Korea, Republic of, Brazil, Japan, Italy, Mexico, France, Greece, Poland, Russian Federation, Austria, Taiwan, Bulgaria, Finland, Turkey
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Australia, Canada, Italy, Norway, Spain, Sweden, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
Peter MacCallum Cancer Centre, AustraliaMelbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...CompletedAcute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, AllogeneicAustralia
-
University Hospital Schleswig-HolsteinDeutsche Krebshilfe e.V., Bonn (Germany)CompletedLeukemiaIsrael, Germany, Italy, Australia, Austria, Czechia, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Switzerland, Canada, Netherlands, Puerto Rico, Australia
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
PfizerRecruitingACUTE LYMPHOBLASTIC LEUKEMIAItaly, Spain, Belgium, Germany, Hungary, Switzerland, Norway, Austria, France, Czechia, Finland, Netherlands, Sweden, Israel, Poland, Greece, Denmark, Slovakia
-
Bristol-Myers SquibbChildren's Oncology Group; EsPhALLCompletedLeukemia, PediatricUnited States, Canada, United Kingdom, Italy, Australia, Puerto Rico
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
University Hospital Schleswig-HolsteinCompletedLeukemiaSwitzerland, Germany, Austria
-
German CLL Study GroupCompletedProlymphocytic LeukemiaGermany, Austria
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Bone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Preleukemia | Chronic Myelomonocytic LeukemiaUnited States, France, Australia, Netherlands, Spain, Germany, United Kingdom, Finland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Malignant Neoplasm | Bacterial Infection | Myeloid Neoplasm | Benign Neoplasm | Methicillin-Resistant Staphylococcus Aureus InfectionUnited States, Canada, Puerto Rico
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Lymphoblastic LeukemiaUnited States, Australia, Canada, Brazil
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Secondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Mucositis | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous... and other conditionsUnited States, Canada, Australia
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
TetraLogic PharmaceuticalsTerminatedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States, Spain, Australia, Germany
-
Novartis PharmaceuticalsAvailableAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-cell Lymphoma (DLBCL)United States, Canada, Australia
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Chronic Myelogenous Leukemia (CML) | Metastatic Gastrointestinal Stromal Tumors (GIST) | Receptor Tyrosine Kinase (KIT) Mutated MelanomaItaly, United Kingdom, Canada, Singapore, Netherlands, France, Korea, Republic of, United States, Slovakia, Hungary, Russian Federation, Hong Kong, Spain, Israel, Sweden, Austria
-
University of UlmGlaxoSmithKline; WiSP Wissenschaftlicher Service Pharma GmbH; German CLL Study...TerminatedThrombocytopenia | Chronic Lymphocytic LeukemiaAustria, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic LeukemiaUnited States, Puerto Rico
-
European Organisation for Research and Treatment...Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedLeukemiaFrance, Belgium, Netherlands, Italy, Portugal, Austria, Germany
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
Jazz PharmaceuticalsChildren's Oncology Group (COG)CompletedAcute Lymphoblastic Leukemia | Lymphoblastic LeukemiaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
PharmaEngineRecruitingAcute Myeloid Leukemia | Lymphoma, Mantle-CellAustralia
-
Novartis PharmaceuticalsCompletedLeukemiaUnited States, Belgium, Netherlands, Canada, Austria, Germany, Australia, United Kingdom, Turkey, France, Poland, Norway
-
Janssen Research & Development, LLCCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited States, United Kingdom, France, Sweden, Germany, Spain, Italy, Belgium, Israel, Netherlands
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
Bristol-Myers SquibbPfizerCompletedLymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada, Mexico, Belgium, Russian Federation, Hungary, Korea, Republic of, Australia, Puerto Rico, Czechia, New Zealand, Poland
-
Therapeutic Advances in Childhood Leukemia ConsortiumTakeda; Children's Hospital Los AngelesActive, not recruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Lymphoma, ChildhoodUnited States, Australia
-
TME Pharma AGCompletedChronic Lymphocytic LeukemiaBelgium, Austria, Italy, France
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand